Elevance Health Inc. Common Stock (ELV)
Stock · NYSE · Health Care
$394.43as of 8/28/2026
Price chart
Open in TradingViewAbout ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based a…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 96,129
- Website
- www.elevancehealth.com/
Fundamentals
- 1-day range
- $394.41$403.12
- Market cap
- $83.01B
- P/E (trailing)
- 17.57
- P/E (forward)
- 13.32
- EPS (trailing)
- $22.50
- Dividend yield
- 1.24%
- Beta
- 0.72
- Avg. volume
- 1.44M
- Ex-dividend date
- September 10, 2026
- Dividend pay date
- September 25, 2026
How Elevance Health Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 6, 2026 · via SEC EDGAR / Finnhub
Forecasts
21 analyst ratings
Elevance Health Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ELVElevance Health Inc. Common Stock$394.81▼ 1.08%Market cap $83.01BP/E 17.57$274.84$436.24
- CIThe Cigna Group Common Stock$278.88▲ 0.44%Market cap $74.53BP/E 11.52$239.51$315.47
- NTRANatera Inc. Common Stock$326.47▼ 3.61%Market cap $38.72BP/E —$157.43$343.18
- CNCCentene Corporation Common Stock$64.77▼ 0.86%Market cap $31.50BP/E —$28.24$69.36
- ILMNIllumina Inc. Common Stock$215.65▼ 5.29%Market cap $29.98BP/E 34.73$88$231.81
- GHGuardant Health Inc. Common Stock$161.76▼ 4.01%Market cap $21.31BP/E —$53.4$176.58
- MOHMolina Healthcare Inc Common Stock$199.88▲ 0.57%Market cap $10.17BP/E 1249.59$121.06$244.89
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ELV Elevance Health Inc. Common Stock | $83.01B | 17.57 | $394.81 | ▼ 1.08% | $274.84$436.24 |
| CI The Cigna Group Common Stock | $74.53B | 11.52 | $278.88 | ▲ 0.44% | $239.51$315.47 |
| NTRA Natera Inc. Common Stock | $38.72B | — | $326.47 | ▼ 3.61% | $157.43$343.18 |
| CNC Centene Corporation Common Stock | $31.50B | — | $64.77 | ▼ 0.86% | $28.24$69.36 |
| ILMN Illumina Inc. Common Stock | $29.98B | 34.73 | $215.65 | ▼ 5.29% | $88$231.81 |
| GH Guardant Health Inc. Common Stock | $21.31B | — | $161.76 | ▼ 4.01% | $53.4$176.58 |
| MOH Molina Healthcare Inc Common Stock | $10.17B | 1249.59 | $199.88 | ▲ 0.57% | $121.06$244.89 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 UpdateSeekingAlpha · 8/26/2026
- Is The Pullback In UNH Stock A Glitch Or A Warning?Yahoo · 8/21/2026
- Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?Yahoo · 8/21/2026
- Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?Yahoo · 8/21/2026
- 2 Large-Cap Stocks with Promising Prospects and 1 Facing HeadwindsYahoo · 8/21/2026
- Can Humana's Star Ratings Rebound Unlock MA Earnings Power?Yahoo · 8/20/2026
- UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?Yahoo · 8/19/2026
- How Should You Approach CVS Health Stock After Q2 Earnings?Yahoo · 8/18/2026
Insider Activity
Insider Actions →- Gail Boudreaux · July 17, 2026 · Buy2.0K @ $368.25
- Gail Boudreaux · July 17, 2026 · Buy680 @ $366.41
- Ramiro G. Peru · July 17, 2026 · Buy1.0K @ $366.05
- Ronald W. Penczek · June 12, 2026 · Sale369 @ $403.16
- Robert L. Dixon Jr. · June 11, 2026 · Sale151 @ $401.77
- Ronald W. Penczek · May 19, 2026 · Option Exercise877 @ $311.48
- Ronald W. Penczek · May 19, 2026 · Option Exercise654 @ $271.27
- Ronald W. Penczek · May 19, 2026 · Sale1.5K @ $403.13
- Bahija Jallal · May 13, 2026 · Grant563
- Antonio F. Neri · May 13, 2026 · Grant563
- Deanna D. Strable-Soethout · May 13, 2026 · Grant563
- Susan D. DeVore · May 13, 2026 · Grant563
- Robert L. Dixon Jr. · May 13, 2026 · Grant563
- Amy W. Schulman · May 13, 2026 · Grant563
- Ramiro G. Peru · May 13, 2026 · Grant563
Institutional Ownership
March 31, 2026
- Total shares held
- 187.15M
- Total value held
- $51.71B
- Institutional holders
- 1452
- Unknown19.89M
- Unknown14.35M
- Unknown10.29M
- Unknown8.23M
- Unknown5.89M
- Unknown5.19M
- Unknown5.14M
- Unknown5.13M
- Unknown4.82M
- Unknown4.75M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 29, 2026
Ruane, Cunniff & Goldfarb Adjust Position in Elevance Health in Q2 Update. A recent portfolio update noted that Ruane, Cunniff & Goldfarb, an established investment firm, adjusted its holdings in Elevance Health during the second quarter. The commentary tracked changes in the firm's portfolio rather than announcing a company-specific event for Elevance Health. The stock is currently trading above the midpoint of its 52-week range and below the average analyst price target, which may be useful context for understanding why portfolio activity in the name is being watched.